CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


09-May-2011
Cerilliant Introduces New Stable-Labeled Internal Standard of N-Desmethylolanzapine-D8

Desmethylolanzapine-D8 diHCl D-070
100 ug/mL (as free base) in Acetonitrile:Water (50:50)

A stable-labeled internal standard for use in LC/MS or GC/MS applications including clinical toxicology analysis, therapeutic drug monitoring, or isotope dilution methods. Desmethylolanzapine is the primary metabolite of olanzapine, marketed as the atypical antipsychotic Zyprexa for the treatment of schizophrenia and bipolar disorder.

Besides Olanzapine-D8 (O-035), Olanzapine (O-024), and its native N-desmethyl metabolite (D-069), we offer certified solution standards of other atypical antipsychotics and their metabolites and internal standards, including aripiprazole, quetiapine, risperidone, clozapine, and ziprasidone.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn